On-Demand CME Activities
Our case-based activities address clinical challenges to optimize treatment plans for patients with AML. Topics include:
- AML treatment timing
- Outcomes for older patients with AML
- AML risk stratification
The Latest HCT Research
Easily stay up-to-date on the latest research advances in hematopoietic cell transplantation (HCT) that is saving lives. Find summaries and references for recent publications.
Partnering to Save Lives
In addition to operating the Be The Match Registry, we also facilitate 6,400 transplants each year, conduct research, and support patients and clinicians. Find out all we do to partner with you to save lives.
Access HCT Clinical Resources
Access evidence-based tools, clinical guidelines, presentation slides, outcomes data, and education courses on HCT.
Disease-Specific Indications and Outcomes
Find the latest references, outcomes, and referral timing guidelines by disease. Access patient-friendly handouts.
On-demand CME: Improving SCD Outcomes
Explore new research impacting treatment decisions for sickle cell disease (SCD). In this CME activity, experts provide strategies for breaking down barriers to patient care, discuss clinical trials for SCD and examine new models for shared decision-making.
Study Shows Age Doesn’t Affect Survival Outcomes in Patients with Non-Hodgkin Lymphoma Who Undergo Allogeneic HCT
Survivorship Care Plan Improves Patient Cancer Care-related Distress Levels for Hematopoietic Cell Transplant Recipients
National Marrow Donor Program® Be The Match® Applauds New Legislation to Protect Patient Access to Life-Saving Transplants for Medicare Beneficiaries
About the Clinicians Section
This section of our health care professional website provides comprehensive information, research, and resources for health care professionals who care for patients before, during, and/or after hematopoietic cell transplant. The National Marrow Donor Program®(NMDP)/Be The Match® is a global leader in facilitating bone marrow and umbilical cord blood transplants to save the lives of patients with leukemia, lymphoma, genetic disorders, and other diseases, and conducts research through our research program, CIBMTR® (Center for International Blood and Marrow Transplant Research).